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Abstract. Golgi a-mannosidase II (G1cNAc transferase
1-dependent a1,3[a1,6] mannosidase, EC 3.2.1.114)
catalyzes the final hydrolytic step in the N-glycan mat-
uration pathway acting as the committed step in the
conversion of high mannose to complex type structures.
We have isolated overlapping clones from a murine
cDNA library encoding the full length a-mannosi-
dase II open reading frame and most of the 5' and 3'
untranslated region. The coding sequence predicts a
type II transmembrane protein with a short cytoplas-
mic tail (five amino acids), a single transmembrane
domain (21 amino acids), and a large COOH-terminal
catalytic domain (1,124 amino acids). This domain or-
ganization which is shared with the Golgi glycosyl-
transferases suggests that the common structural motifs
may have a functional role in Golgi enzyme function
or localization.
Three sets of polyadenylated clones were isolated
extending 3' beyond the open reading frame by as
N
AND O-GLYCAN structures are increasingly being
found to contribute to biological recognition events
during development, oncogenic transformation,and
cell adhesion (3, 10, 11, 37, 38, 40). The enzymes involved
in thematuration ofcell surface andintracellular N-glycans
are found in the endoplasmic reticulum and Golgi complex
where they act upon newly synthesized glycoproteins to
generate an array of different structures from a common
oligosaccharide precursor (18). The N-glycan processing
pathway consists ofthree stages : (a) the initial synthesis of
a dolichol-linked precursor oligosaccharide andthe en bloc
transfer of the oligosaccharide to newly synthesized poly-
peptide Asn-X-Ser/Thr sequons on the lumenal face of the
ER; (b) the trimming of the high mannose structures by
a-glucosidases and a-mannosidases in the ER and Golgi
complex; and (c) the elaboration ofthe branched oligosac-
charide chains by Golgi glycosyltransferases. The trimming
phase of the pathway is accomplished by a-glucosidases I
and II as well as a collection of processing a1,2-manno-
sidases (29) in the ER and Golgi complex. The resulting
Man5GlcNAc2 structure is then modified by the addition of
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much as 2,543 bp. Northern blots suggest that these
polyadenylated clones totaling 6.1 kb in length corre-
spond to minor message species smaller than the full
length message. The largest and predominant message
on Northern blots (7.5 kb) presumably extends another
N1.4-kb downstream beyond the longest of the isolated
clones. Transient expression of the a-mannosidase II
cDNA in COS cells resulted in 8-12-fold overexpres-
sion of enzyme activity, and the appearance of cross-
reactive material in a perinuclear membrane array
consistent with a Golgi localization. A region within
the catalytic domain of the a-mannosidase II open
reading framebears a strong similarity to a correspond-
ing sequence in the rat liver endoplasmic reticulum
a-mannosidase and the vacuolar a-mannosidase of
Saccharomyces cerevisiae. Partial human a-mannosi-
dase II cDNA clones were also isolated and the gene
was localized to human chromosome 5.
a single G1cNAc by G1cNAc transferase I (GnT 1),' before
the finalhydrolytic steps in thepathwayare accomplished by
a-mannosidase II (Man 11), catalyzing the removal ofa1,3-
and a1,6-mannosyl residues (50). Thetrimmingand elonga-
tionphases ofthe pathwayoverlapattheGnTI/ManII steps,
with each reaction being obligatory for further processing
steps. GnTI is essential forprocessing tohybrid or complex
type structures (34), whiletheabsence ofManII activity, ei-
ther by inhibition with the alkaloid, swainsonine (52), orin
the human autosomal genetic disease hereditary erythro-
blastic multinuclearity associated with positive acidified se-
rum(HEMPAS), characterized bythe reduced expression of
Man11(12), results inthe accumulationofAsn-linkedhybrid
oligosaccharides in lieu of the standard array of complex
type structures. The cleavage ofglycoprotein processing in-
Dr. Moremerfs present address is Complex Carbohydrate Research Center,
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1. Abbreviations used in this paper: GnT I, G1cNAc transferase I; Man II,
ci-mannosidase II; PCR, polymerase chain reaction.termediates by Man II also confers resistance to cleavage by
endoglycosidase H, a commonly used marker for transit
through the Golgi complex (42).
A number of the mammalian Golgi glycosyltransferases
havebeen cloned recently (1, 7, 17, 21, 25, 32, 45, 46, 53, 56)
allowing a comparison of the polypeptide structures and the
ability to examine the regulation of transferase expression
in relation to terminal oligosaccharide processing events.
Among these enzymes a common domain motifhas been de-
scribed (37) of a type II transmembrane structure with a
small NHz-terminal cytoplasmic tail, a single transmem-
brane domain, a variable stem region, and a large 000H-
terminal catalytic domain. Among the processing hydro-
lases, only an a-mannosidase presumably responsible for
the removal of a single a1,2-mannosyl linkage in the ER has
been fully cloned (2). This enzyme bears no resemblance to
the glycosyltransferase domain structure, but it does share
extensive homology to the yeast vacuolar a-mannosidase.
Both enzymes contain no classical signal sequence or mem-
brane-spanning domain. Characterization of the primary
structures and molecular aspects of the early processing
steps therefore await the cloning and characterization of
the remainder of the processing a-glucosidases and a-man-
nosidases.
The most well characterized of the processing a-man-
nosidases is Man lI. The enzyme has been purified and
extensively characterized from rat liver(for review see refer-
ence 29) . It is a transmembrane glycoprotein with an ap-
parent molecular mass of 124 kD by SDS-PAGE and a cata-
lyticdomain facing the lumen of the Golgi complex. Release
of a 110AD catalytically active soluble form of the enzyme
can be accomplished by a mild chymotrypsin digestion of
permeabilized or solubilized Golgi membranes (28). The
chymotrypsin-cleaved form ofthe enzyme has been purified
and is catalytically indistinguishable from the intact enzyme
(30), while it differs in NH,-terminal sequence and hydro-
phobic character. NHz-terminal sequence data from the 110-
kD soluble form of the enzyme along with internal peptide
sequences have allowed us to generate a Man II-specific
cDNA probe by mixed oligonucleotide-primed amplification
of cDNA (26). A partial cDNA clone was isolated from an
oligo(dT)-primed rat liver cDNA library which spanned
-40% of the Man II open reading frame. We present here
the isolation of cDNA clones which span the entire open
reading frame and much of the 5' and 3'untranslated regions
of Man II from a random- and oligo(dT)-primed murine
cDNA library. The open reading frame confirms the map of
peptide sequence data from the purified rat protein demon-
strating that Man II conforms to the domain structure model
common among the Golgi glycosyltransferases. Transient
expression of a full length murine Man II cDNA clone in
COS cells directs the overexpression of enzyme activity and
the synthesis of immunoreactive material in a perinuclear
membrane array consistent with the localization of the Man
II polypeptide in the Golgi complex of the transfected cells.
Materials andMethods
Materials
Restriction enzymes were purchased from New England Biolabs (Beverly,
MA) or Bethesda ResearchLaboratories (Gaithersburg, MD). 4-methylum-
belliferyl a-D-mannoside, and trypsin were from Sigma Chemical Co. (St.
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Louis, MO). 150-200 g maleSprague-Dawley rats were from Charles River
Breeding Laboratory (Wilmington, MA). Bincinchoninic acid (BCA) pro-
tein assay reagent was from Pierce Chemical Company (Rockford, IL).
XZAP II cloning vector and the invitro transcription/capping kit were from
Stratagene (La Jolla, CA). Sequenase was from United States Biochemical
(Cleveland, OH). The Cyclone Biosystem M13 deletion kit was from Inter-
national Biotechnologies Inc. (New Haven, CT). Zetaprobe membranes
were from Bio-Rad (Richmond, CA). Rabbit reticulocyte lysates, micro-
sontal membranes and RNasin were from Promega (Madison, WI). Tran-
[3sS]_label (1,024 Ci/mmol) was from ICN Radiochemicals (Irvine, CA).
N-glycanase was from Genzyme (Cambridge, MA). FITC-conjugated goat
anti-rabbit antibody was from Cappel Laboratories (Cochranville, PA).
DNA from a human/hamster hybrid somatic cell panel was from BIOS
Corp. (New Haven, CT). Taq polymerase was from Perkin Elmer (Nor-
walk, CT). The pXM vector was a gift from Harvey Lodish (Massachusetts
InstituteofTechnology, Cambridge, MA). Allother reagents were ofat least
reagent grade and obtained from standard suppliers.
Assays andPreparation ofCellExtracts
Man II wasassayed using4-methylumbelliferyl a-D-mannosideas substrate
as described (27). NaCl-washed microsomal membranes from COS cell
monolayers were prepared from four 100-mm culture dishes (90%
confluent) exactly as previously described for 3T3 cells (27). Protein con-
centration was determined using the BCA protein assay reagent asdescribed
by Pierce Chemical Co. (Rockford, IL) using BSA as standard.
ScreeningoftheMurine andHumancDNALibraries
An unamplified BALB/c 3T3 cDNA library primed with a mixture of
oligo(dT) and random hexamers and packaged into a XZAP II cloning vec-
tor (Stratagene) was obtained from D. J. G. Rees (Massachusetts Institute
of Technology) (41). An amplified version ofthe same library was used in
the second round of screening. A similarly prepared amplified HepG2
cDNA library was obtained from E. Marcantonio (Columbia University,
NewYork, N.Y.). Thepackaged librarieswereplated on XLl-Bluehostcells
and screened by plaque hybridizationusing standard procedures. Theprobe
that was used for library screening and blot hybridizations (see below) was
a 1,170 by Man II PCR amplification fragment (PCR-1) generated from a
ratliver cDNA preparation by amplification with Man II-specific degener-
ate and inosine-substituted oligonucleotide primers designed using protein
sequence data from the purified Man II polypeptide (26).
DNA Sequencing
Selected XZAP II clones were subcloned into M13 and sequenced by the
dideoxy" chain termination method (43) using deoxyinosine triphosphate
in place of dGTP and Sequenase (United States Biochemical) as described
by the manufacturer. Sequence data were obtained from successive dele-
tions in M13 using T4 polymerase (Cyclone Biosystem, International Bio-
technologies Inc., New Haven, CT) or using synthetic oligonucleotide
primers. Oligonucleotides were synthesized on an Applied Biosystems
(model 380B) DNA synthesizer.
RNA Hybridization
RNA was prepared from adult male rat tissues as described (2) . Indicated
quantities of poly(A+) RNA were resolved on a 1% formaldehyde/agarose
gel (26) and transferredby capillary blotting to a Zetaprobe membrane(Bio-
Rad Laboratories). Filters were prehybridized, hybridized, and washed as
described (6) using the rat PCRl cDNA amplification product (26) as the
radiolabeled probe.
In Vitro Transcription and Translation
Clone MII-8 containing the entire Man II open reading frame inserted into
the EcoRl site ofpBluescript II (see Fig. 1) was linearized by digestion with
BamHI and transcribed in vitro using the T7 polymerase promoter of
pBluescript II and the in vitro transcription kit from Stratagene. RNA syn-
thesis was carried out for 2 h at 37°C in a 40 pl reactionvolume containing
40 mM Tris HCl (pH Z5), 50 mM NaCl, 8 mM M9Clz, 2 mM spermi-
dine, 0.3 mM M~G(5)ppp(5)G, 30 mM l7rT, 80 U RNasin, 0.5 mM each
ATP, UTP, and CTP, 0.17 mM GTP, 10 U of T7 polymerase, and 5,ug of
the linearized clone MII-8 template. After the addition ofGTP to 0.5 mM
the reaction was continued for another 16 h at 37°C. The reaction mixture
was extracted twice with phenol/chloroform/isoamyl alcohol followed by
1522ethanolprecipitation . Control reactions containedplasmidwithoutinsert or
plasmid with a noncoding insert.
Translation in vitro was carried out for 1.5 h at 30°C in a 25,ul reaction
volume containing all amino acids except methionine (1 mM each), 40 U
RNasin, 25 pCi of a mixture of [35S]L-cysteine and [35S]L-methionine
(Tran 35S-label, ICN Radiochemicals, 1,024 Ci/mmol), the RNA synthe-
sized above, and a rabbit reticulocyte lysatepreparation from Promega. In-
cubationscontaining dog pancreasmicrosomalmembranes werecarried out
by addition of 1 .8 icl of microsomal membranes (Promega)/25-p1 reaction
eitherbefore orfollowing the translationreaction . Posttranslational addition
of microsomal membranes was followed by a 45-min incubation at 30°C .
Samples were either denatured directly in SDS sample buffer or processed
for proteolysis by the addition of trypsin (Sigma Chemical Co.) to 100
jig/ml, t 0.1% Triton X-100, followedby incubationat 0°C for 1 h. Proteol-
ysis was terminated by addition of 30 KIU of aprotinin and boiling in SDS
sample buffer. SDS-PAGE and autoradiography were carried out as de-
scribed (26) .
Transient RansfectionofCOSCells
COS cells were grown in 100-mm culture dishes in a humidified incubator
at 37°C in 5% COz with DME media containing 0.1 fcg/ml penicillin and
streptomycin and 10% FCS (DME/10% FCS) . Confluent cell monolayers
weretrypsinized and split 1:8 two daysbefore transfection . The largeEcoRI
fragment from clone MII-8 containing theentire Man IIopen reading frame
was excisedandligated into the EcoRI siteof thepXM COS cell expression
vector (58) . Recombinant plasmids were checked by restriction mapping to
confirm the correct orientation of the insert. COS cells (80% confluent)
were transfected either with the pXM without an insert, pXM containing
the Man II insert in the correct orientation (MII-pXM), orpXM containing
the Man II insert in the antisense orientation (asMII-pXM) by liposome-
mediated transfection (Lipofectin ; Bethesda Research Labs, Gaithersburg,
MD) as described by the manufacturer. Briefly, 20 kg of the relevant plas-
mid were mixed with 50 A,1 of Lipofectin reagent in 3 ml of serum-free
medium(Opti-MEM ; Bethesda Research Labs)and incubated at roomtem-
perature for 15 min. Monolayer cultures wererinsed twice with Opti-MEM
and incubated with the 3 ml media containing the plasmid/lipofectin mix-
ture tbr 6-8h at 37°C. The cultures were rinsed twice with DME/10% FCS
and incubated with DME/10% FCS at 37°C for24-72 h . Cells prepared for
inrmunofluorescence studies were plated oncoverslipsplaced in 24-well rni-
crotiter plates, grown to 50 % confluency, and transfected at the same plas-
mid/Lipofectin/Opti-MEM ratio as in the larger scale transfections (total
volume of 200 pl/well) .
Biosynthetic Labeling ofNIH-373 CellsandCOSCells
NIH-3T3 cells were grown in 100-mm culture dishes inDME containing
10% calf serum. For biosynthetic labeling 3T3 or COS cells in 100-mm
plates were washed twice with Met-free DME and incubated in Met-free
DME for 30 min . Cells were then labeled for 60 min at 37°C with 4 ml
Met-freeDME containing 120 ttCi/nil [35S]-labeled mixture of methionine
and cysteine (Trap 35S-label, 1,024 Ci/mmol ; ICN Radiochemicals) . Cell
monolayers were washed with DME/10% FCS and chased for 60 min with
Figure 1. Schematic represen-
tation of murine and human
Man II clones . The rat PCR-1
probe used to isolate murine
Man II clone MII-8 and hu-
man Man II clone HM-1 was
derived from mixed oligonu-
cleotide primed amplification
of cDNA (41) . The stippled
boxes representtheDNA frag-
ments used as probes . The
openboxes on the clone MII-8
and MII-48diagrams represent
theMan II open reading frame and the noncoding region is represented by the black line. The crosshatched box on the HM-1 clone diagram
represents the portion of the human Man II open reading frame corresponding to the murine open reading frame. The segment of the
humancDNA sequence used in chromosome mapping is shown at the bottom . Indicated restriction sites are : P, PstI; B, Bg1II ; K, KpnI ;
X, XhoI ; R, EcoRI ; H, HindIII . A scale in by is given at the top of the figure .
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the unlabeled medium . Cells werecollected by trypsinization, washed twice
in PBS, and vigorously resuspended in lysis buffer containing 1% Triton
X-100, 0.5 M NaCl, 20mM Tris HCl, pH 7.5 . The extract was clarified by
centrifugation at 200,000 g for 30 min in a centrifuge (TL-100; Beckman
Instruments, Inc., Palo Alto, CA) using a TLA 100.3 rotor at 2°C. The
clarified extracts were preadsorbed with 100 Wl of a 50% (vol/vol) slurry
ofproteinASepharose beads (Phamtacia Fine Chemicals, Piscataway, NJ)
for 1 h at4°C. After theremoval ofthe beads by centrifugation, 5 p1 ofanti-
Man II antiserum (27) was added andincubated at4°C for 4h with constant
mixing. Protein ASepharose was added (50 Wl of the 50% slurry) and the
mixture was incubated for an additional 2 h at 4°C with mixing. The im-
munoprecipitates were washed, eluted, and resolved by SDS-PAGE as pre-
viously described (27) . Samples digested with N-glycanase (Genzyme)
were processed as described (27) .
Indirect Immunofluorescence
Cell monolayers werefixed at the indicatedtime posttransfection by washing
three times with PBS and incubating for 15 min at 37'C in a 3.7% solution
of formaldehyde in PBS. Coverslips were removed from the wells, washed
with PBS, and permeabilized by incubation for 1 min in a solution of100%
methanol at -20°C . After washing with PBS the cells were incubated in
a solution containing 1% FCS in PBS for 30 min at room temperature fol-
lowed by a 30-min incubation at 30°C with a 1:2,000 dilution ofanti-Man
II antibody (27) in PBS. The coverslips were washed again in PBS and in-
cubated for 30 min at 30°C with a 1:1,000 dilution of a FITC-conjugated
goat anti-rabbit antibody (Cappel Laboratories) in PBS containing 1%
FCS. Cells were observed andphotographed using an Axioplan microscope
(Carl Zeiss, Oberkochen, Germany) .
Chromosome Mapping
Human Man II-specific primers were synthesized to assay for the presence
of the human Man II gene in a human/hamster somatic cell hybrid panel .
DNA isolated froma panel of 25 human/hamster hybrids (50 pg/ml, BIOS
Corp .) was screened by PCR using primers with the following sequence :
sense primer-GCTCGGATGCTACTAGA (3/17 mismatch with murine Man
11) ; antisense primer-TCTTAACTTTAAACTTGGA (7/19 mismatch with
murine Man II) bracketing a 178 by of the human Man II gene which was
not interrupted by introns (see Fig . 1) . Amplification reactions (25 pl) con-
taining 50mM KCI, 10 mM Tris HCl (pH 8.3), 1.5 mM MgC12, 200pM
eachdNTP, 50 ng genomic DNA, 0.5AM each primer, and 0.6U Taq poly-
merase. A temperature cycle of 92°C (1 min), 55°C (1 min), and 72°C
(2 min) was repeated for 35 cycles followed by an extension of 4 min at
72°C. Amplificationproducts wereresolved on a 2% agarosegel containing
ethidium bromide and scored for the presence of the 178-bp human Man
II amplification fragment .A faint 178-pb band as well as several character-
istic nonspecific bands were found in hamster controls and in hu-
man/hamster hybrids lacking chromosome 5, but the human amplification
product could be unambiguously detected above this background by a
greater yield, the presence ofunique HindUI and EcoRl sites, and theDNA
sequence of the human Man II cDNA (data not shown) .601
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Figure 2. Nucleotide sequence of the cDNA encoding murine Man II and the predicted amino acid sequence. The single open reading
frame is shown directly above the nucleotide sequence. Both nucleotides and amino acids are numbered from the beginning of the open
reading frame. Nucleotides 5' of the first in-frame ATG codon are given negative numbers. The putative membrane spanning domain is
indicatedby a solidline above the protein sequence. Amino acid residues indicated by a solidbox are regions ofthe murine protein sequence
that matches the rat Man II peptide sequence data. Amino acids residues indicated by a dashed box represent conservative substitutions
from the rat peptide sequences. Underlined aminoacid residues represent residues that could not be determined during peptide sequencing.
Asterisks indicate potential glycosylation sites. In the 3' untranslated region the putative polyadenylation signals are indicated by a dashed
underline. A black dot is under the position where a poly(A) tractwas found on a respectiveset of polyadenylated clones. Thesesequence
data are available from EMBL/GenBank/DDBJ under accession number X61172.
ComputerMethods
DNA sequence data was assembled into acontiguous sequence database by
the method of Staden (49). Sequence comparisons against the GenBank or
GenPept sequence databases were performed using the FASTA program
(39). Statistical analysis of sequence similarity between two protein se-
quences was determined usingthe Bestfitprogram ofthe University ofWis-
consin Genetics Computer Group (version 6.2) or the sequence similarity
investigation program (DIAGON) of Staden (49).
Results
Isolation andCharacterization
ofcDNA Clones EncodingMurineand
Human ct-Mannosidase II
We have previously isolated a partial cDNA clone encoding
-40% of the rat Man II open reading frame (26) using a
probe isolated by mixed oligonucleotide-primed amplifica-
tion of cDNA (PCR-1). SinceNorthern blots demonstrated a
message size of -7.5 kb (adjusted downward from the previ-
ously published -8 kb; 26) we decided to perform subse-
quent rounds of screening using a library primed with both
oligo(dT) and random hexamers (41) . Approximately 1 x
106 independent recombinants from the unamplified 3T3
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cDNA library were screened with the 1,170 by rat Man II
PCR probe (26) . 36 independent positive clones were ob-
tained, the longest being -4.4 kb in length (clone MII-8,
Fig. 1) and terminating at the 3' end with a ti70-bp poly(A)
tract 19 by downstreamfrom a consensus AATAAA polyad-
enylation signal (54) (base position 4253 in Fig. 2) . This
clone and several others in the open reading frame region
were sequenced yielding the entire Man II open reading
frame (3,550 bp) and 86 and 827 by of 5' and 3' untranslated
sequence, respectively (Fig. 2). Among the isolated clones
several terminated at base position 3,848 followed by a poly(A)
tract of >50 bp. 24 bases upstream from the poly(A) tract
was another ATTAAA consensus polyadenylation signal
(Fig. 2). Despite containing the entire Man II open reading
frame and a poly(A) tail, clone MII-8 was N3 kb smaller
than the predominant message size on Northern blots. Based
on the extended 3' untranslated region of previously cloned
Golgi enzymes (46, 53, 56) wehypothesized that the remain-
ing message length extended further in the 3' direction. The
730 by EcoRl fragment on the 3' end ofclone MII-8 was used
as a probe to re-screen the 3T3 cDNA library and an addi-
tional 16 independent clones were obtained. The longest of
these clones (clone MII-48) extended an additional 1.7 kb intro translation products were obtained ifthe samples were
cessing (data not shown) . Molecular weight markers (in
the 3' direction and terminated with a poly(A) tract 19 by
downstream from anotherAATAAA consensus polyadenyla-
tion signal . The size of the aggregate clone sequence is in
close agreement with the -6 .1 kb minor message on North-
em blots (see Fig . 5, lane 1) . The heterogeneity in termina-
tion and polyadenylation within the 3' untranslated region
suggests that the additional sequence necessary to generate
the predominant -7.5-kb message will likely result from an
extension of an additional x+1.4 kb beyond the 3' end of the
MII-48 clone sequence .
We have also screened a human HepG2 cDNA library
with the rat PCR amplification product (PCR-1) as a probe
to isolate human cDNA clones for sequencing and for use
as hybridization probes . These probes have been used to ex-
amine the expression ofMan II in HEMPAS disease (12), a
heterogeneous disease characterized in some individuals by
a deficiency in Man II . The sequence has also been used to
designhumanMan II specific primers for chromosome map-
ping by PCR (see below) . The HepG2 library was screened
(4 X 105 recombinants) and three independent clones were
isolated . The longest ofthe clones (ti1.9 kb) contained -55
ofthehuman Man II open reading frame and aligned to posi-
tion -5 to +1,928 on the 3T3 sequence in Fig . 2 (Fig . 1) .
Sequence Analysis
The murine Man II coding sequence predicts a polypeptide
of 1,150 amino acids (M, 131,000) with a single type II
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Figure3 In vitrotranscription/
translation of Man II clone
MII-8andcomparisonwithbio-
synthetically labeled Man II .
Man II clone MII-8 was tran-
scribed in vitro using T7 po-
lymerase as described in Ma-
terials and Methods . In vitro
translation wasperformedwith
or without the addition of mi-
crosomal membranes (co- or
posttranslational addition of
membranes) as indicated at
the bottom of the figure . Ali-
quots of the translation were
thendigested or mock digested
with trypsin in the presence or
absence of Triton X-100 as in-
dicated . Samples wereresolved
by SDS-PAGE and subjected
to autoradiography. Lanes A
and B represent cell extracts
from biosynthetically labeled
3T3 cells which were immu-
noprecipitated with the anti-
Man II antibody and either di-
gested (B) or mock digested
(A) with N-glycanase . Sam-
ples wereresolvedon the same
gel as the in vitro translation
samples . LanesA and Bwere
exposed to x-ray film for 3 d
while the in vitro translation
samples wereexposed for 12 h .
Identical results for the in vi
immunoprecipitated with anti-Man II antibody following the synthesis and pro-
kD) are indicated at the left of the figure .
transmembrane domain from amino acid residue 6-26. Sev-
eral lines of evidence suggest that the coding region shown
in Fig . 2 contains the correct initiation site for the Man II
open reading frame. The Met codon in position 1 is the first
ATG in the sequence and conforms to the consensus eu-
caryotic translation sequence with a purine at position -3,
the most critical residue in the initiation sequence (19) . The
5' untranslated region is G/C rich (68%), a characteristic
common to several ofthe Golgi glycosyltransferases (46, 53)
and also a common feature among housekeeping genes (9) .
Finally, the NHZ-terminal peptide sequence of the purified
intact rat liver enzyme starts at residue 6 of the predicted
open reading frame (30) . The purified enzyme is indistin-
guishable in size from the biosynthetically labeled 3T3 en-
zyme (27) and the enzyme detected by Western blots from
freshly prepared Golgi membrane extracts (27), but the
cleavage of five residues would be too small a change to de-
tect on SDS gels during purification . Although the cleavage
of the five residue cytoplasmic tail most likely reflects in
vitro proteolysis during purification, it could also possibly
represent the product of cleavage in vivo .
The in vitro transcription/translation of the clone MR-8
cDNA also resulted in a band of identical mobility to the
deglycosylated 3T3 enzyme (Fig . 3) . Translation in vitro in
the presence of microsomal membranes resulted in the
glycosylation of the polypeptide and a decrease in mobility
to a doublet of identical size to that of the glycosylated 3T3
1526Yeast Man
￿
YEQGE-SQVLTNVYGIGNCHIDTAWLWPFAE-TRRKIVRSWSSQCTLMDRFPEYKFVASQAQQFK--WLLEDHPEFFNKVLIPK
Man II QGFDIKYEADEWDHEPLQVFVVPHSHNDPGWLKTFNDYFRDKTQYIFNNMVLKLKEDSSRKFMWSEISYLAKWWDIIDIPK--KEAVKSL
ER Man EALASKFFGQRGGESQHTIHATGHCHIDTAWLWPFKETVR-KCARSWSTAVKLMERNTEFTFACSQAQQLE--WVKNQYPG-LYAQLQEF
160 170 180 190 200 210 220 230
Yeast Man IQQSQFFAVGGTWVENDTNIPSGESLARQFFFGQRFFLKHFGLKSKIFWLPDTFGYSSQMPQLCRLSGIDKFLTQKLSWNNINSFP-HST
Man II LQNGQLEIVTGGWVMPDEATPHYFALIDQLIEGHQWLEKNLGVKPRSGWAIDPFGHSPTMAYLLKRAGFSHMLIQRVHYAIKKHFSLHKT
:11 : 1 :1 :11 1 : : I 1 : : 1 : : :1 : : : : : : :1 . . . I 1 :11 :1 : . . . . . I . . I I . . . . . I I
ER Man ACRGQFVPVGGTWVEMDGNLPSGEAMVRQFLQGQNFFLQEFGKMCSEFWLPDTFGYSAQLPQIMQGCGIKRFLTQKLSWNLVNSFPHH--
240 250 260 270 280 290 300 310 320
Yeast Man F------NWAGIDGSQLLTHMPPGNTYTAD
.
￿
II : . . . . :I II I :I
Man II LEFFWRQNWDLGSATDILCHMMPFYSYDIPH
:III
￿
:I : . . . :I I : I II : .
ER Man -TFFWE---GLDG-SQVLVHFPPGDSYGMQG
Figure 4. Comparison of murine Man II protein sequence with the yeast vacuolar a-mannosidase and the rat ER a-mannosidase. Murine
Man II was aligned with the yeast vacuolar a-mannosidase and the rat ER a-mannosidase using the FASTA program (54). The sequences
in the figure show the individual alignments of murine Man II (center sequence) with the yeast vacuolar a-mannosidase (59) (Yeast Man,
upper sequence) and the rat ER a-mannosidase (24) (ER Man, lower sequence). The vertical bar indicates amino acid identities between
the two lines ofsequence. The double dots indicate conservative amino acid substitutions between the two lines of sequence. The numbering
below the aligned sequences refers to the polypeptide numbering of3T3 Man II in Fig. 2. When the indicated sequence pairs were subjected
to statistical analysisusing theBestfit program from the University ofWisconsin Genetics ComputerGroup (comparison versus randomized
sequences with the same amino acid content, gap weight = 3, gap length weight = 0.1) the sequence alignments were found to be 9.7
and 6.0 SDs above random for the Man II/yeast vacuolar a-mannosidase pair and the Man II/ER a-mannosidase, respectively.
biosynthetic product. The doublet likely results from the
glycosylation of Asn residue 1,129 and a partial glycosylation
at Asn residues 78 or 93, since the purified soluble form of
the rat liver enzyme (residues 107-1,150) has been shown to
be fully glycosylated at a single site (30). The apparent mo-
lecular weight on SDS gels is slightly less than is predicted
for the open reading frame of the cDNA (rv117 kD vs 131
kD for the deglycosylated forms, respectively). This pre-
sumably results from an anomalous gel migration since the
in vitro translation product and the product of biosynthetic
labeling run at an identical position by SDS-PAGE. Transla-
tion in the presence ofmembranes also resulted in the appar-
ent co-translational translocation of the polypeptide across
the lipid bilayer. Trypsin cleavage of the in vitro translation
products in the presence of microsomal membranes did not
alter the amount or the mobility ofthe glycosylated form but
the smaller in vitro-synthesized products were fully suscep-
tible to digestion. The lack ofa mobility shift following tryp-
sin digestion also confirms the orientation in the membrane
and the location of the membrane-spanning domain. These
results are also consistent with the inability to detect any
cytoplasmically oriented polypeptide in protease protection
experiments in intact Golgi membranes (27) . Addition of
membranes posttranslationally did not result in a significant
production of glycosylated product suggesting a requirement
for co-translational translocation of the enzyme.
In addition to the NHZ-terminal peptide sequence, the
mouse equivalent ofthe six remaining rat Man II polypeptide
sequences determined previously (30) were all found in the
Man II open reading frame confirming the predicted peptide
sequence map (Ref. 30, Fig. 8). Chymotrypsin has been used
to cleave Man II in vitro generating a soluble catalytically
active form of the enzyme (28, 30). The cleavage site is at
residue 107 in the open reading frame and predicts that the
cytoplasmic tail, transmembrane domain, and 80 residues of
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lumenally oriented polypeptide are not essential for enzyme
activity.
Although Man II appears to have the domain structure
common to the other Golgi glycosyltransferases no direct se-
quence homology was found with any of the glycosyltrans-
ferases. The previously described similarity between rat
Man II and rabbit GnT 1 (45) was found to be marginally
significant (4 SDs above random). When the murine and hu-
man Man II equivalents of this sequence were compared to
either the rabbit or human (15) GnT I sequences the similari-
ties were even less significant (2.1 and 1.7 SDs above random
for the murine and human Man II sequences, respectively).
Comparison of the Man II polypeptide to a translated form
of the GenBank database (GenPept, version 64.3) revealed
that a 215 amino acid region of Man II bears a statistically
significant similarity to a corresponding region in the rat ER
a-mannosidase (2) and the vacuolar ci-mannosidase from
Saccharomyces cerevisiae (59) (6.0 and 9.7 SDs above ran-
dom, Fig. 4). The rat ER a-mannosidase and the yeast vacu-
olar a-mannosidase share extensive homology across their
entire length (2), whereas Man II shares a more limited
similarity within a region of the soluble catalytic domain of
the enzyme. All three enzymes recognize a-mannoside link-
ages and cleave the synthetic substrates p-nitrophenyl a-D-
mannoside and 4-methylumbelliferyl a-D-mannoside, but
differ in their specificity toward natural high mannose oligo-
saccharides, inhibition by alkaloid inhibitors, antibody cross-
reactivity, and subcellular-_Iocalization (2, 29, 59, 60). The
sequence similarity and the common activity toward syn-
thetic substrates between the three enzymes would, however,
suggest that this region may represent a portion ofthe active
site involved in a-mannoside recognition.
Comparison of the sequence of the 3' untranslated region
of murine Man II with the GenBank database (version 67.0)
revealed that the extended 3'-untranslated region contains aFigure 5. Tissue distribution ofMan 11 mRNA . Poly(A) RNA (5 jig) was resolved on a 1% agarose/formaldehyde gel, except for lane
15 where 15 wg poly(A) RNA was loaded . The gel was blotted onto a nylon membrane and probed with a radiolabeled ratcDNA probe
as described in Materials and Methods . Location ofradiolabeled size standards (Bethesda Research Laboratories) are as indicated (in kb) .
Arrows indicate the positions of the major and minor message species in rat tissues. The blot in lane 1 was exposed to x-ray film for 8 d
at -70°C. The gel in the remaining lanes was exposed for 2 d at 70°C .
single interrupted copy of a mouse Bl repetitive sequence
(data not shown), the mouse equivalent of the human Alu
consensus sequence (20, 48) .
TYssue Distribution ofMan IIRNA
The isolation ofseveral size classes ofpolyadenylated clones
that differ in their degree of extension in the 3' untranslated
region demonstrates the heterogeneous nature of the termi-
nation and polyadenylation of the Man 11 message. Each of
Table I . a-Mannosidase Activity in COS Cell Transfectants
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the separate polyadenylated clones contains an upstream
consensus polyadenylation signal yet their abundance on
Northern blots appears to be inversely proportional to their
length ; the 7.5-kb transcript being N10-fold more abundant
than the 6.1 kb transcript (Fig. 5, lane 1) and N50-100-fold
greater than the 4.3- or 4.0-kb transcripts (barely visible in
Fig . 5, lane 1 but readily visible with longer exposure) . A
Northern blot of poly(Al) RNA from several rat and mouse
tissues was prepared using samples identical to those used
for the rat ER a-mannosidase (2) . A predominant Man II
Assays were carried out as described in Materials and Methods for 40 min at pH 5.6 with 4-methylumbelliferyl a-o-mannoside as substrate . Activity at this pH
also detects the lysosomal and ER a-mannosidases (27), both of which can be found predominantly in the postmicrosomal supernatant fraction. Four 100-mm
plates of COS cell monolayers were used to prepare homogenates for each plasmid transfection . Parallel transfections and fractionations were carried out with
COS cells mock transfected without the vector or with the Man II insert inpXM in the antisense orientation (asMII-pXM) . Both samples gave results essentially
identical to pXM without an insert .
MII-pXM pXM (no insert)
Activity Specific activity Activity Specific activity Increase
pmol/min pmol/min/mg wmol/min pmol/min1mg -fold
Homogenate 53 .4 21.4 13 .8 5.5 3.9
Postnuclear supernatant 32 .7 23.4 9 .1 6.5 3.6
Salt-washed microsomes 26 .5 52.9 2 .2 4.3 12.3
Postmicrosomal supernatant 6 .3 7.0 6.9 7.6 0.9U '.
E
m a ~:
0
rn E
0 =L
pH
Figure 6. pH profiles ofa-mannosidase activity in COS cells trans-
fected with control (pXM, o) or Man II clone MII-8 (MII-pXM,
o) constructs. Salt-washed membranes were prepared and assayed
as described in Materials and Methods with the 4methylumbel-
liferyl a-n-mannoside substrate at the indicated pH. Membranes
prepared from COS cellstransfected with MII-pXM were also as-
sayed at the indicated pH inthe presence of 10 AM swainsonine (0).
Residual a-mannosidase activity in the supernatant following im-
munoprecipitation of the salt-washed membrane extract with anti-
rat Man II antibody is as indicated (m).
transcript of 7.5 kb was found in all tissues with the greatest
enrichment being in adrenal and thymus. Most other tissues
resulted in an autoradiographic band of -3-10-fold lesser
intensity except skeletal muscle which was undetectable ex-
cept with prolonged exposure. The ratio of the multiple Man
II message species appeared constant across the rangeof rat
tissues despite the >100-fold difference in the level ofexpres-
sion between adrenal and muscle tissues. Comparison with
the rat ER a-mannosidase (2), reveals that while the Man II
transcript is most abundant in adrenal and thymus, the ER
enzyme has a highest abundance level in adrenal and testis
and minor differences in other tissues except spleen, intesti-
nal epithelia, and muscle tissues which have a slightly re-
duced levelofmessage. The differences with Man II message
expression in the thymus, testis, and muscle suggests that
there is a differential tissue expression of the two a-manno-
sidases at least in these tissues. A low but detectable level
of Man II message was also found in rat brain tissues consis-
tent with a report of reduced levels of Man II activity in rat
brain and the presence of a novel brain a-mannosidase (51)
which is not sensitive to inhibitionby swainsonine and is able
to directly cleave high mannose structures to Man3GlcNAc2
without the prior addition of a G1cNAc residue by GnT I.
Whether the message levels adequately reflect the levels of
the Man II enzyme activity in the brain or inthe other tissues
remains to be determined. Although there is a >100-fold
difference in Man II autoradiographic intensity on Northern
blots between thymus and muscle, it is also not clear if this
merely reflects the biosynthetic leveland the degree of elabo-
ration of the Golgi complex and the secretory pathway/gly-
cosylation machinery in the respective tissue types.
Transient Expression ofMan II in COS Cells
The large EcoRI fragment of clone MII-8 containing the en-
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tire Man II open reading frame was subcloned into the COS
cell expression vector pXM. This is an SV-40-based expres-
sion vector driven by the adenovirus major late promoter
(58) . COS cells were transfected and assayed for Man II ac-
tivity either in cell homogenates or in membrane fractions.
Crude homogenates showed approximately threefold overex-
pression of 4-methylumbelliferyl a-mannoside activity (Ta-
ble I), but Man II activity in crude homogenates is com-
monly masked by the lysosomal a-mannosidase or the ER
a-mannosidase when using synthetic substrates. A salt
washed membrane fraction was prepared which has been
shown to result in the enrichment ofManII activity (27) . As-
says of this membrane fraction revealed a 8-12-fold overex-
pression of 4-methylumbelliferyl a-mannoside activity in
COS cells transfected with MII-pXM when compared cells
transfected with the vector alone or vector with an antisense
insert (Table I). This degree of overexpression is similar to
the activity levels seen for the 01,4-galactosyltransferase ex-
pressed in COS cells(24). The overexpressed Man II activity
has a pH optimum of 5.5, identical to the endogenous en-
zyme in 3T3 cells (27), it is sensitive to inhibition by swain-
sonine, and is immunoprecipitable with antibody to the
purified rat enzyme (Fig. 6) . Biosynthetic labeling of trans-
fected COS cells resulted in a >10-fold overexpression ofim-
munoprecipitable polypeptide (data not shown) reflecting
the high rate of biosynthesis of the vector encoded polypep-
tide 48 h after transfection.
Immunofuorescence ofTransfeciod COS Cells
Immunocytochernistry at the EM level using antibodies to
purified rat Man II has demonstrated the Golgi localization
of the enzyme in rat tissues (44) . The antibodies have also
been used recently as a marker for Golgimembrane compo-
nents in cell trafficking studies (8, 22; and C. Zuber, A.
Nakano, K. W. Moremen and J. Roth, manuscript submitted
for publication). Preliminary studies have shown that the an-
tibody raised to the rat enzyme does not cross react with the
COS cell enzyme (data not shown) allowing a minimal im-
munofluorescence background in the host cells. Transfection
of COS cells with the pXM construct containing the Man II
insert in the sense orientation (MII-pXM) resulted in an anti-
ManII immunofluorescencepattern within 24 h ofthe initia-
tion oftransfection. The immunofluorescence was largely re-
stricted to a crescent shaped reticular pattern adjacent to the
nucleus, but occasionally this reticular structure would ex-
tend well into the cytoplasm (Fig. 7, A and B). This pattern
of immunofluorescence has been previously shown to be
characteristic ofthe Golgicomplex (22, 31, 44) . Mock trans-
fections, transfections with vector alone, or with the Man II
insert in the antisense orientation resulted in no detectable
immunofluorescence signal (data not shown) . Similarly, im-
munofluorescence offixed but not permeabilized cells trans-
fected with MII-pXM resulted in no detectable fluorescence
signal. The transfection efficiency ofthe MII-pXM construct,
as measured by thepercentageof fluorescence-positive cells,
was variable, but ranged from 5-25 R . By 36 h posttransfec-
tion the intensity of the peri-nuclear immunofluorescence
increased substantially with many cells generating an addi-
tional diffuse particulate pattern of fluorescence in the cyto-
plasm consistent with ER staining (8, 22, 31) (Fig. 7, C-E) .
By 48 h postuansfection immunofluorescence staining adja-
cent to the nucleus remained intense but the particulate cyto-Figure 7 . Immunofluorescence studies on COS cells transfected withMan lI cloneMII-8 inpXM (MIIpXM) . Cellswere transfected with
MII-pXM and fixed with formaldehyde either 24 h (A and B), 36 h (C-E) or 48 h (F) posttransfection. Cells were permeabilized and
stained with anti-rat Man II antibody. Within one day of transfection there was a strong fluorescence signal appearing as acup or patch
adjacent to one side of the nucleus in 5-25% of the transfected cells (E) . After36 hthe fluorescence staining wasmore intense with occa-
sional extensions (arrows) of fluorescent signal extending radially into the cytoplasm . By 48 h the fluorescence was quite intense, with
the predominant signal adjacent to the nucleusbut significant fluorescence in a particulate pattern throughout the cytoplasm . Bar, 10 ,um .
The Joumal of Cell Biology, Volume 115, 1991
￿
1530TableII. DiscordancyAnalysis ofa Panel of
25 Hamster/Human Hybrid Clones
Human Man II amplification fragment/chromosome
Total
The human chromosome compliment of each hybrid was compared with the
ability to generate the 178-bp human ManII amplification fragment following
PCR. Concordant segregationofthe amplification fragment was observedonly
for chromosome 5. All other chromosomes were excluded as the site for the
Man II gene by discordancies in at least 15 hybrids. Hybrid clones containing
the indicated chromosome in at least 5% of the cells were considered positive
for the chromosome in the discordancy analysis.
plasmic staining greatly increased. With the high level of
Man II synthesis late in the transient expression, detection
of early biosynthetic intermediates in the ER or an accumu-
lation of aggregated enzyme in the ER might be expected.
Chromosome Mapping of the Human Man II Gene
Comparisonof the murine Man II cDNA with the sequence
of the partial human Man II clone revealed that the DNA se-
quences are 84 % identical at the DNA level and 85 % identi-
cal at the amino acid level (data not shown). Primers were
designed to a region ofthe human Man II cDNA which was
distinct from the murine cDNA sequence (3/17 and 7/19 mis-
matches, respectively) and produced a clear 178-bp PCR
product with the human Man II cDNA sequence upon am-
plification with human genomic DNA. Amplification with
hamster genomic DNA resulted in a faintband at 178 pb that
was distinguishable from the human amplification product
both in quantity and by the absence ofthe HindIII and EcoRI
sites characteristic of the human Man II genomic sequence.
DNA from a human/hamster somatic cell hybrid panel (4)
was tested for the amplification of the 178-bp human Man
II fragment. Cell lines which scored positive for the human
Man II PCR fragment were also all found to contain human
chromosome 5 (Table I). One of the lines (hybrid line 212)
contained multiple deletions in 5q and several lines con-
tained deletions in the 5p15.1-5pl5.2 region. All of these
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lines scored positive for amplification of the human Man II
fragment. All other chromosomes were excluded as the site
for the Man II gene by discordancies in at least 15 of the hy-
brid lines.
Discussion
Man II occupies a central position in the Asn-linked
oligosaccharide processing pathway acting as the committed
step in the synthesis ofcomplex type structures (29) . The en-
zyme has long been considered a marker for the Golgi com-
plex by cell fractionation (14) and immunocytochemistry
(35), as well as beingthe biochemical marker responsible for
the conversion of N-linked glycans to structures which are
resistant to cleavage by endoglycosidase H (50). Intact Man
II has been purified and characterized from rat liver (29) and
shown to be a disulfide-linked homodimer (30) with a cata-
lytic domain oriented toward the Golgilumen. Protease pro-
tection experiments in intact Golgi membranes were unable
to detect any cytoplasmically oriented polypeptide (28) . The
release of a soluble form of the enzyme following chymo-
trypsin digestion ofsolubilized Golgimembranes allowed us
to purify and compare the intact and soluble forms of the en-
zyme demonstrating that the soluble catalytic domain retains
all of the catalytic characteristics of the intact enzyme. The
cloning of the full-length murine Man II open reading frame
has allowed us to demonstrate that Man II shares several of
the biochemical features of the Golgi glycosyltransferases
(37), namely a type II transmembrane orientation with an
NH2-terminal membrane anchor domain and susceptibility
to proteolytic release of a soluble, catalytically active form
of the enzyme.
Several lines of evidence indicate that the isolated cDNA
clone MII-8 encodes the authentic Man II polypeptide. The
NH2-terminal sequence of the intact purified enzyme aligns
to amino acid position 6 of the translated cDNA at the junc-
tion of the cytoplasmic tail and the transmembrane domain.
Whether the cleavage of the five amino acids segment rep-
resents an in vivo or in vitro event is difficult to determine
since it is not possible to distinguish the cleaved from un-
cleaved forms based on size. The remaining six rat poly-
peptide sequences can be identified in the translation of the
murine cDNA with several conservative amino acid substitu-
tions between the two species. The Man II cDNA clone tran-
scribed and translated in vitro was found to yield a polypep-
tide identical in size, glycosylation pattern, and topology in
microsomal membranes to the rat liver (28) or biosyntheti-
cally labeled 3T3 enzyme (27) . Expression of the Man II
cDNA in COS cells resulted in a 8-12-fold overexpression
of enzyme activity with the same pH optimum, sensitivity
to inhibition by swainsonine, and crossreactivity with the
anti-rat Man II antibody as the endogenous 3T3 enzyme
(27). Finally, the enzyme expressed in COS cells was local-
ized by immunofluorescence to a perinuclear membrane ar-
ray characteristic of the Golgi complex suggesting an appro-
priate localization of the transfected cDNA translation
product. The open reading frame predicts a type II trans-
membrane topology with a 5 amino acid cytoplasmic tail,
a single transmembrane domain, a "stem" region of at least
80 amino acids based on proteolysis studies, and a 1,044
amino acid catalytic domain. Although the combined "stem"
and catalytic domains are two to three times larger than most
Chromosome Concordant Discordant Percent discordant
1 6 19 76
2 4 21 84
3 5 20 80
4 5 20 80
5 25 0 0
6 7 18 72
7 5 20 80
8 6 19 76
9 6 19 76
10 6 19 76
11 6 19 76
12 7 18 72
13 9 16 64
14 10 15 60
15 7 18 72
16 6 19 76
17 3 22 88
18 3 22 88
19 10 15 60
20 6 19 76
21 10 15 60
22 7 18 72
X 6 19 76
Y 7 18 72of the glycosyltransferases, the general features of mem-
brane topology are identical between the two classes of en-
zymes (37) .
Transmembrane topologies of plasma membrane and ER
proteins are quite varied (55) suggesting thatthere is no obvi-
ous selective advantage of a single topology for membrane
protein function. Many of the Golgi glycosyltransferases
(37), as well as Man II (28), retain full catalytic activity
when released from their membrane anchoring domains
by selective proteolysis either in vivo or in vitro suggesting
that the cleaved regions exert little, if any, influence on the
catalytic activities of these enzymes. The conservation of
topological features between the collection of Golgi glyco-
syltransferases and a processing hydrolase, Man II, might
therefore suggest a functional role for the common domain
structure beyond a simple attachmentofthe catalytic domain
to the membrane surface. One function that has been pro-
posed (37) for the "stem" region is to confer flexibility to the
catalytic domains ofthe Golgienzymes in order to allow ac-
cessibility to lumenal and membrane associated substrates.
Although this hypothesis provides a logical resolution to the
problem of substrate accessibility, evidence for this "hinge"
or "stem"has yet to be demonstrated either in vitro or in vivo.
A Golgi GDPase from S. cereWsiae (57) which cleaves the
soluble substrate GDP in the yeast Golgi lumen has recently
been cloned and sequenced (C. Abeijon, K. Yanagisawa,
K. W. Moremen, C. B. Hirschberg, and P W Robbins, un-
published results) and was found to contain a similar type II
transmembrane structure. Since this enzyme presumably
cleaves only soluble substrates it would suggest that the con-
served topological features of Golgi enzymes might have a
function distinct from providing flexibility to the catalytic
domain.
Another potential role for the tail/transmembrane do-
main/stem regions of these Golgi enzymes would be in the
recognition and retention of the polypeptides in the Golgi
stacks. Recognition signals for soluble and membrane bound
polypeptides in the ER have been described. The tetrapep-
tide recognition signal, KDEL, on the COOH termini of
soluble, lumenal ER proteins results in their recognition and
retention in the ER (31). Recently, a recognition signal for
ER type I transmembrane proteins has also been described
(16, 33, 36, 47) with the recognition sequence KKXX at the
COOH termini of the polypeptide sequences being recog-
nized on the cytoplasmic face of the ER (47). Deletions
in the first of three transmembrane domains of the avian
coronavirus El glycoprotein disrupted the cis-Golgi local-
ization of this polypeptide suggesting that a membrane-
associated region contains at least a portion of the informa-
tion of Golgi targeting of this viral glycoprotein (23). The
Golgi cisternae have an additional level of complexity, how-
ever, since many of the endogenous Golgi enzymes exhibit
distinctive sub-Golgi compartmentation. The mechanistic
requirements necessary to yield these subtle differences in
Golgi localization may therefore be more complex than the
simple linear sequences involved in ER protein retention.
The similarity in sequence between murine Man II, the rat
ER a-mannosidase, and the yeast vacuolar a-mannosidase
was surprising considering the distinctions between the en-
zymes on substrate specificity and sensitivity to alkaloid in-
hibitors. All three enzymes recognize the small synthetic
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substrates, p-nitrophenyl a-D-mannoside and 4-methylum-
belliferyl a-D-mannoside, although with different Ks (29).
These results suggest that the region of similarity might
reflect a portion of the catalytic domain involved in a-man-
noside recognition. The mammalian lysosomal a-manno-
sidase (5) also cleaves the small synthetic a-mannoside sub-
strates and, like Man II, is inhibited by swainsonine. When
the lysosomal enzyme is cloned and the sequence is deter-
mined a comparison with the consensus sequence of the
other a-mannosidases would be a critical test of the function
of the consensus sequence. A match in the proposed sub-
strate recognition region between the three disparate mam-
malian a-mannosidases would provide strong evidence that
this region is involved in the active site of the enzymes.
The 3' end of Man II was found to be heterogeneous in
length with the isolation ofthree distinct size classes of poly-
adenylated clones. The longest class of clones extends 2,543
by in the 3' direction from the end of the open reading frame
before terminating in a poly(A) tract. Comparison between
the longest aggregate clone sequence and the message size
on Northern blots suggests that the predominant transcript
likely reads through the region containing the three polyade-
nylation signals and uses a termination and polyadenylation
signal an additional -1.4 kb further downstream. Repetitive
element sequences were found in the long 3' untranslated re-
gion of both murine Man II and murine 51,4-galactosyltrans-
ferase (46) . Although this type of extended 3' untranslated
region is common among the glycosyltransferases the func-
tional significance of this extended transcript is not clear.
The identification of a deficiency in Man II expression as
the causative agentin one form of HEMPAS disease (12), a
heterogeneous autosomal disease characterized by a defect
in the synthesis of cellular and secreted glycoproteins (13),
has focused our interest on the genomic structure of Man II
and the regulation ofgene expression. As a first step we have
presented the cloning and expression of murine Man II
cDNA. In addition we have localized the humanMan II gene
to chromosome 5. Further characterization of full length hu-
man Man II cDNA and genomic clones should allow us to
determine the molecular basis of the Man II deficiency in
HEMPAS disease and the regulatory features of the process-
ing enzymes responsible for these maturation of cellular and
secreted N-glycans.
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